Evidence supporting the use of: Bifidobacterium bifidum
For the health condition: Vaginitis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bifidobacterium bifidum is a probiotic that has been studied for its potential role in supporting vaginal health, including the treatment or prevention of vaginitis. The vagina is normally colonized by beneficial bacteria, predominantly Lactobacillus species, which help maintain an acidic environment and inhibit the growth of pathogens. However, some studies suggest that Bifidobacterium species, including B. bifidum, may also contribute to a healthy vaginal microbiota, particularly in cases where lactobacilli are depleted.

Clinical research directly assessing the efficacy of B. bifidum for vaginitis is limited. Most available studies focus on multi-strain probiotic formulations containing Lactobacillus and Bifidobacterium species together. These studies suggest that oral or intravaginal probiotics may help restore microbial balance and reduce symptoms of bacterial vaginosis or vulvovaginal candidiasis, but the specific contribution of B. bifidum alone is unclear. A few small trials and in vitro studies indicate that B. bifidum can inhibit pathogens relevant to vaginitis (such as Gardnerella vaginalis and Candida albicans), but this evidence is preliminary.

In summary, while there is some scientific rationale and emerging evidence supporting the use of B. bifidum for vaginitis, the evidence base is not robust, and more high-quality, strain-specific clinical trials are needed. Its use is scientifically plausible, but current support is modest, warranting a rating of 2 out of 5.

More about bifidobacterium bifidum
More about Vaginitis